Immunology of Ebola Vaccine

Clinical trial NCT06100913 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06100913
Sponsor: Emory University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ebola Virus Disease

Start date: 2024-08-06
Primary completion: 2027-08-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.